Isatuximab is a medication used to treat multiple myeloma, a type of blood cancer. It works by targeting a specific protein on cancer cells, helping the immune system to identify and destroy these cells.

Evorpacept is an experimental medication being studied for the treatment of multiple myeloma. It is designed to block a signal that cancer cells use to avoid being detected by the immune system.

Dexamethasone is a corticosteroid medication that helps reduce inflammation and suppress the immune system. In multiple myeloma treatment, it is often used in combination with other medications to enhance their effectiveness and manage symptoms.

Multiple Myeloma – A type of blood cancer that develops in plasma cells, which are white blood cells that help fight infections. In this condition, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. These abnormal cells produce large amounts of defective antibodies called M proteins. The disease can weaken bones, reduce kidney function, and decrease the production of normal blood cells. Multiple myeloma often progresses slowly and can affect multiple areas of the body, particularly the bones of the spine, skull, pelvis, rib cage, and hips.

Cancer – A disease characterized by the uncontrolled growth and spread of abnormal cells in the body. These cells divide rapidly and can form masses called tumors, which can interfere with normal body functions. Cancer cells can break away from their original location and spread to other parts of the body through blood vessels and lymph nodes. The disease develops when genetic changes interfere with normal cell growth and division control mechanisms. Different types of cancer can affect various organs and tissues throughout the body.